Are you interested in clinical trials of new Migraine medications?
Clinical trials of medications and other treatments for Migraines, headaches, and other conditions are conducted for a variety of reasons. They gather data to determine if medications and other treatments are effective, if they're safe, what potential side effects they may... Read more
The FDA has approved a new prescription medication for the acute treatment of Migraine attacks, Cambia, developed by Kowa Pharmaceuticals America (KPA). Cambia is a combination of diclofenac (brand name Voltaren), a non-steroidal anti-inflammatory drug (NSAID) and potassium bicarbonate. In clinical trials, Cambia was shown to be effective for... Read more
Almotriptan, better known as Axert and Almogran, is one of eight triptan medications developed to abort a Migraine attack in adults. Until now, there has not been an FDA approved Migraine abortive treatment for adolescents under the age of 18.
This week there was exciting news: the FDA approved Axert for... Read more
Are you interested in clinical trials of new Migraine medications?
Clinical trials of medications and other treatments for Migraines, headaches, and other conditions are conducted for a variety of reasons. They gather data to determine if medications and other treatments are effective, if they're safe, what potential side effects they may... Read more
There are over 36 million American Migraineurs suffering day in and day out with Migraine and headache pain. Dr. Lawrence Newman, director of the Headache Institute at the Roosevelt Hospital in New York City, recently discussed some of the reasons he feels Migraine treatments fail and patients aren't getting the relief they... Read more